Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Harvard Business School
Medtronic
Colorcon
McKesson

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INDINAVIR SULFATE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

INDINAVIR SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0571-43 360 CAPSULE in 1 BOTTLE (0006-0571-43)
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0573-62 180 CAPSULE in 1 BOTTLE (0006-0573-62)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Medtronic
McKinsey
Merck
AstraZeneca